Streetbeat News

Products Services

JSDA

Jones Soda Co. has launched its cannabis-infused brand, Mary Jones, in Washington state dispensaries. The THC craft soda is available in 12- and 16-ounce cans with THC infusion levels of 10mg and 100mg. The manufacturing and distribution operations are managed by CompCanna Inc., a Washington-licensed cannabis processor, and Dogtown Pioneers, Inc. The company plans to expand into Michigan and Nevada. JSDA shares were trading down at 1.32% at $0.187 at market close Friday afternoon.

Portfolio Pulse from Joana Scopel

October 02, 2023 | 2:30 pm

GFS

LMT

NVDA

GlobalFoundries Inc (NASDAQ:GFS) has become a significant player in the semiconductor industry, with its chips being integral components in various electronic devices. The company's chips have contributed to the boom of Nvidia Corp (NASDAQ:NVDA). GlobalFoundries has made significant investments in Singapore, Germany, France, and upstate New York to enhance its production capacity and technological capabilities. The company has also forged strong alliances with giants in the automotive and defense sectors, including an exclusive deal with Lockheed Martin Corp (NYSE:LMT) and a $3 billion agreement with the U.S. Department of Defense.

Portfolio Pulse from Anusuya Lahiri

October 02, 2023 | 2:24 pm

GLMD

Galmed Pharmaceuticals has been granted European Patent Number EP3538158 for the treatment of fibrosis, including methods for inhibition of fibrotic disorders and hepato-fibrotic conditions associated with NAFLD and NASH.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 2:24 pm

ICCM

IceCure Medical announced that an independent study validated its ProSense cryoblation treatment as a safe and effective outpatient procedure for breast cancer with a 96.8% success rate. This news has led to a rise in the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 2:21 pm

JPM

KBE

KRE

XLF

JP Morgan Chase & Co. CEO Jamie Dimon discussed banking and AI on Bloomberg TV. He mentioned the potential of AI in banking and its implications for the future of the industry.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 2:07 pm

JPM

SPY

Jamie Dimon, CEO of JPMorgan Chase, stated in an interview with Bloomberg TV that artificial intelligence (AI) is a 'real, living thing' and it's going to bring significant changes.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 2:07 pm

SGML

Sigma Lithium Corporation (NASDAQ:SGML) has announced that its Greentech Plant has reached a record daily peak production of 890 tonnes of Triple Zero Green Lithium, equivalent to an annualized production of 320,000 tonnes. The company is on track to achieve its annual 2023 production guidance of 130,000 tonnes. The plant has exceeded its design utilization rate of 85%, running at 88%, and has evolved to 100% design capacity. The company has been actively contributing to the preservation of water and biodiversity.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:53 pm

DMTTF

PSIL

The article discusses recent developments in the field of psychedelic therapies for mental health disorders. Small Pharma's (OTC:DMTTF) Phase 1b study on DMT and SSRIs for major depressive disorder (MDD) has released new findings. TheraPsil, a Canadian non-profit, has launched an MDMA-assisted psychotherapy training program. Apex Labs' psilocybin macrodose drug protocol has been approved for a Canadian veteran's treatment-resistant depression. The AdvisorShares Psychedelics ETF (NYSE:PSIL) has been on a slow downtrend. Other companies mentioned include GH Research (NASDAQ:GHRS), COMPASS Pathways (NASDAQ:CMPS), Mind Medicine (NASDAQ:MNMD), Enveric Biosciences (NASDAQ:ENVB), Bright Minds Biosciences (NASDAQ:DRUG), Silo Pharma (NASDAQ:SILO), Atai Life Sciences (NASDAQ:ATAI), FSD Pharma (NASDAQ:HUGE), Incannex Healthcare (NASDAQ:IXHL), Lucy Scientific Discovery (NASDAQ:LSDI), and Cybin Inc. (NYSE:CYBN).

Portfolio Pulse from Lara Goldstein

October 02, 2023 | 1:46 pm

NVTA

The U.S. Food and Drug Administration (FDA) has granted de novo marketing authorization for the Invitae Common Hereditary Cancers Panel, a DNA test that can detect genetic variants associated with an elevated risk of developing certain cancers. This is the first test of its kind to be granted FDA marketing authorization. The test evaluates DNA from a blood sample to identify variants in 47 genes known to be associated with an elevated risk of developing certain types of cancer.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:43 pm

M

Toys R Us is planning a robust re-entry into the U.S. market with plans to launch as many as 24 new stores. The company is also exploring retail avenues at airports and cruise ships. The parent entity of Toys R Us, WHP Global, unveiled its expansion strategy 'Air, Land and Sea'. The company's inaugural airport outlet is set to open in November at the Dallas/Fort Worth International Airport. WHP also revealed plans to set up over 400 new Toys R Us outlets within Macy's Inc locales countrywide.

Portfolio Pulse from Shivani Kumaresan

October 02, 2023 | 1:27 pm